SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 69 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $388,000 | +84.8% | 42,419 | +12.7% | 0.00% | – |
| Q4 2018 | $210,000 | -76.6% | 37,651 | -50.0% | 0.00% | -100.0% |
| Q3 2018 | $896,000 | +131.5% | 75,302 | +98.8% | 0.00% | – |
| Q2 2018 | $387,000 | +31.2% | 37,880 | +66.7% | 0.00% | – |
| Q1 2018 | $295,000 | +33.5% | 22,718 | 0.0% | 0.00% | – |
| Q4 2017 | $221,000 | -33.8% | 22,718 | 0.0% | 0.00% | – |
| Q3 2017 | $334,000 | -8.7% | 22,718 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $366,000 | +363.3% | 22,718 | +360.5% | 0.00% | – |
| Q1 2017 | $79,000 | +31.7% | 4,933 | 0.0% | 0.00% | – |
| Q4 2016 | $60,000 | -11.8% | 4,933 | 0.0% | 0.00% | – |
| Q3 2016 | $68,000 | – | 4,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |